You just read:

Trovagene Announces Initiation of Enrollment for Phase 1b/2 Clinical Trial in KRAS-Mutated Colorectal Cancer at Leading Comprehensive Cancer Centers

News provided by

Trovagene, Inc.

Jul 09, 2019, 08:00 ET